Eli Lilly & Co. and Novo Nordisk A/S are asking a federal court to reject legal protections to drug compounders making ...

After its potential kidney disease drug went down in flames late last year, Novo Nordisk is pinning the blame on alleged fraudulent claims by the drug’s original maker. | After its potential kidney ...

Discover Nova Measurements' impressive growth, rising shares, and strong future projections. Explore key factors driving ...

NovaBay Pharmaceuticals has completed the sale of its Avenova brand and related assets to Physician Recommended ...

Received overwhelming shareholder support in favour of take-private transaction with AditxtAdvanced key pipeline programs, engaged regulatory ...

In a report released today, Greg Harrison from Scotiabank maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price ...